The April edition of Genetic Engineering News contains an article by Dr Satnam Surae, Aigenpulse Chief Product Officer, on how Cutting-Edge Biotechs Need Cutting-Edge Software. Don’t let your life sciences data become a bloated mess. Ensure that, however much your data grows, it stays relevant and accessible. How? Use an intelligence platform, says Aigenpulse’s Satnam […]
The Summer edition of Drug Discovery World contains an article by Dr Satnam Surae, Aigenpulse Chief Product Officer, on Data-Driven Transformation in drug discovery. It reviews the current approach to data management and its application within the drug development and research setting, highlighting major critical challenges and emerging solutions for organisations that need to harness […]
What is Big Data? How can 1) the Life Sciences Sector Capitalise on Data Technologies? 2) you Establish the Right Environment? 3) Enable a Culture of Success? What are the Keys for Success? Our White Paper has the answers.
ABSTRACT Driven by the adoption of next generation high-throughput technologies, the size of data created by scientific experiments is growing exponentially, placing a huge burden on R&D teams and hindering the drug discovery process. Data is siloed on individual workstations, impractical to audit (e.g. for FDA regulations) and integrity is compromised. Digitalising research processes with […]